Biocon Intimates Analyst Investor Meeting Schedule

Biocon Limited intimates BSE and NSE of its management's scheduled participation in investor conferences pursuant to SEBI Listing Regulation 30(6).
The company explicitly states it will not disclose any Unpublished Price Sensitive Information (UPSI) during these meetings with analysts and institutional investors.
The disclosed meeting schedule is noted as subject to change due to exigencies on the part of investors or the company itself.
This information will be made available on the company's official website at www.biocon.com for public access.